CSF3 and neutropenia: Furthermore, the outcomes from the dynamic record of ANC demonstrated a steady ascending curve after the delivery of rHSA/G-CSF with few risks of grade 4 neutropenia, and the ANC at the end of the corresponding intermission was within the normalized boundary.